search
Back to results

Aerobic, Resistance, Inspiratory Training Outcomes in Heart Failure (ARISTOS-HF)

Primary Purpose

Heart Failure

Status
Completed
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Aerobic-Resistance-Inspiratory
Aerobic-Resistance
Aerobic-Inspiratory
Aerobic Training
Sponsored by
Onassis Cardiac Surgery Centre
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Heart Failure focused on measuring Rehabilitation, Exercise, Training

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Chronic heart failure (from New York Heart Association (NYHA) functional class II to NYHA III)
  • Left ventricular ejection fraction below or equal to 35%

Exclusion Criteria:

  • Uncontrolled arrhythmia
  • Pulmonary oedema or pulmonary congestion in the last 30 days
  • Cognitive, neurological or orthopaedic limitations
  • Respiratory infection during 30 days before the start of the study
  • Pulmonary limitations (e.g COPD)

Sites / Locations

  • Onassis Cardiac Surgery Center
  • Asklepieion Voulas General Hospital
  • Telecardiology Center, Institute of Cardiology

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Active Comparator

Active Comparator

Active Comparator

Arm Label

ARIS group

AT/RT group

AT/IMT group

AT group

Arm Description

Aerobic-Resistance-Inspiratory

Aerobic-Resistance

Aerobic-Inspiratory

Aerobic Training

Outcomes

Primary Outcome Measures

change in peak oxygen consumption (peakVO2, in ml/kg/min) using cardiopulmonary exercise testing (Medgraphics CPX/MAX, Medical Graphics Corp.,St. Paul, MN, USA, ZAN 600, ZAN Messgera¨te GmbH, Germany)
evaluation of maximal exercise capacity
change in left ventricular dimension (mm) using resting 2-dimensional echocardiography (Ultrasound Vivid 7 or 6, General Electric Healthcare, Fairfield, CT, USA) with the Teichholz method
evaluation of cardiac structure (LVEDD, LVESD in mm)

Secondary Outcome Measures

change in walking distance using the 6-minute walking test (6MWT)
evaluation of submaximal exercise capacity
change in quality of Life using the Minnesota Living with Heart Failure questionnaire
evaluation of life quality
Preference Program Survey
Questionnaire to evaluate exercise program preference (most enjoyed program) using a scale from 1 (=Very Little) to 5 (=Excellent)
change in left ventricular ejection fraction, echocardiography (Ultrasound Vivid 7 or 6, General Electric Healthcare, Fairfield, CT, USA) with the biplane Simpson' s method
evaluation of LVEF%

Full Information

First Posted
December 22, 2016
Last Updated
May 1, 2020
Sponsor
Onassis Cardiac Surgery Centre
Collaborators
Asklepieion Voulas General Hospital, National Institute of Cardiology, Warsaw, Poland
search

1. Study Identification

Unique Protocol Identification Number
NCT03013270
Brief Title
Aerobic, Resistance, Inspiratory Training Outcomes in Heart Failure
Acronym
ARISTOS-HF
Official Title
Aerobic, Resistance, Inspiratory Training Outcomes in Heart Failure. The ARISTOS-HF Trial: a Prospective Randomized Multicenter Trial
Study Type
Interventional

2. Study Status

Record Verification Date
April 2020
Overall Recruitment Status
Completed
Study Start Date
September 2016 (undefined)
Primary Completion Date
August 2019 (Actual)
Study Completion Date
May 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Onassis Cardiac Surgery Centre
Collaborators
Asklepieion Voulas General Hospital, National Institute of Cardiology, Warsaw, Poland

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study investigates the effects of aerobic, resistance, inspiratory training modalities outcomes in functional capacity and quality of life of heart failure (HF) patients, aiming for the 'optimum' (greek, αριστος=aristos) training program for HF patients.
Detailed Description
Heart failure is a clinical syndrome characterized by symptoms of dyspnea, exercise intolerance and decreased quality of life. A weakness in both inspiratory and peripheral muscles is also reported. Aerobic training (AT) improves the functional status of HF patients (level of evidence IA). Additional benefits of inspiratory muscle training (IMT) and/or resistance training (RT) when combined with aerobic training (AT) in HF symptoms have also been found. Four exercise groups will be studied in order to identify the optimum exercise program I. Aerobic-Resistance-Inspiratory training (ARIS) group II. Aerobic Training-Resistance Training (AT/RT) group III. Aerobic training-Inspiratory Muscle Training (AT/IMT) group IV. Aerobic Training (AT) group

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure
Keywords
Rehabilitation, Exercise, Training

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
88 (Actual)

8. Arms, Groups, and Interventions

Arm Title
ARIS group
Arm Type
Experimental
Arm Description
Aerobic-Resistance-Inspiratory
Arm Title
AT/RT group
Arm Type
Active Comparator
Arm Description
Aerobic-Resistance
Arm Title
AT/IMT group
Arm Type
Active Comparator
Arm Description
Aerobic-Inspiratory
Arm Title
AT group
Arm Type
Active Comparator
Arm Description
Aerobic Training
Intervention Type
Other
Intervention Name(s)
Aerobic-Resistance-Inspiratory
Intervention Description
Patients will be submitted to a 12 week, 3 times/week, continuous aerobic (e.g. bike) training programme at an intensity of 60-80% max HR (or peakVO2) for 30 min combined with resistance training at an intensity of 50% of 1 Repetition Maximum (1RM) for quads training and upper limb exercises (elbow flex/shoulder flex/abd) using dumbbells (1-2 kg) (12-15 reps/3sets) for 10 min, combined also with inspiratory muscle training with a flow-resistive loading system at an intensity of 60% of maximal inspiratory pressure/sustained maximal inspiratory pressure (PImax/SPImax) for 20 min (Aerobic (30min) + Resistance (10min) + Inspiratory (20min) = 60 min)
Intervention Type
Other
Intervention Name(s)
Aerobic-Resistance
Intervention Description
Patients will be submitted to a 12 week, 3 times/week, continuous aerobic (e.g. bike) training programme at an intensity of 60-80% max HR (or peakVO2) for 30 min combined with resistance training at an intensity of 50% of 1RM for quads training, pectoralis m, serratus anterior m, and latissimus dorsi m and upper limb exercises (elbow flex/shoulder flex/abd) using dumbbells (1-2 kg) (12-15 reps/3sets). (Aerobic (30min) + Resistance (30min) = 60 min)
Intervention Type
Other
Intervention Name(s)
Aerobic-Inspiratory
Intervention Description
Patients will be submitted to a 12 week, 3 times/week, continuous aerobic (e.g. bike) training programme at an intensity of 60-80% max HR (or peakVO2) for 30 min combined with inspiratory muscle training with a flow-resistive loading system at an intensity of 60% of maximal inspiratory pressure/sustained maximal inspiratory pressure (PImax/SPImax) for 30min (Aerobic (30min) + Inspiratory (30min) = 60 min)
Intervention Type
Other
Intervention Name(s)
Aerobic Training
Intervention Description
Patients will be submitted to a 12 week, 3 times/week continuous aerobic (e.g. bike) training programme at an intensity of 60-80% max HR (or peakVO2) for 30 min combined with callisthenics progressing to treadmill or bike (at the same intensity) for 30 min (Aerobic training = 60 min)
Primary Outcome Measure Information:
Title
change in peak oxygen consumption (peakVO2, in ml/kg/min) using cardiopulmonary exercise testing (Medgraphics CPX/MAX, Medical Graphics Corp.,St. Paul, MN, USA, ZAN 600, ZAN Messgera¨te GmbH, Germany)
Description
evaluation of maximal exercise capacity
Time Frame
Before and after 12 weeks
Title
change in left ventricular dimension (mm) using resting 2-dimensional echocardiography (Ultrasound Vivid 7 or 6, General Electric Healthcare, Fairfield, CT, USA) with the Teichholz method
Description
evaluation of cardiac structure (LVEDD, LVESD in mm)
Time Frame
Before and after 12 weeks
Secondary Outcome Measure Information:
Title
change in walking distance using the 6-minute walking test (6MWT)
Description
evaluation of submaximal exercise capacity
Time Frame
Before and after 12 weeks
Title
change in quality of Life using the Minnesota Living with Heart Failure questionnaire
Description
evaluation of life quality
Time Frame
Before and after 12 weeks
Title
Preference Program Survey
Description
Questionnaire to evaluate exercise program preference (most enjoyed program) using a scale from 1 (=Very Little) to 5 (=Excellent)
Time Frame
After 12 weeks
Title
change in left ventricular ejection fraction, echocardiography (Ultrasound Vivid 7 or 6, General Electric Healthcare, Fairfield, CT, USA) with the biplane Simpson' s method
Description
evaluation of LVEF%
Time Frame
Before and after 12 weeks
Other Pre-specified Outcome Measures:
Title
Change in dyspnoea using the Borg scale (0-10) at the end of exercise testing
Description
evaluation of dyspnea
Time Frame
Before and after 12 weeks
Title
Change in maximal inspiratory pressure (PImax in cmH2O) using an electronic pressure manometer with computer software (TRAINAIR®, Project Electronics Ltd, London, UK).
Description
evaluation of inspiratory muscle strength
Time Frame
Before and after 12 weeks
Title
Change in inspiratory work capacity (sustained maximal inspiratory pressure (SPImax in cmH2O/s) using an electronic pressure manometer with computer software (TRAINAIR®, Project Electronics Ltd, London, UK).
Description
evaluation of an inspiratory muscle endurance index
Time Frame
Before and after 12 weeks
Title
Change in skeletal muscle strength will be evaluated using the quadriceps 1 repetition maximum (1RM)
Description
evaluation of skeletal muscle strength
Time Frame
Before and after 12 weeks
Title
Change in skeletal muscle endurance will be evaluated using the quadriceps muscle endurance with the product: 50%1Repetition Maximum x max number of reps
Description
evaluation of skeletal muscle endurance
Time Frame
Before and after 12 weeks
Title
Morbidity Records
Description
Evaluate Morbidity
Time Frame
6 months and 12 months after completion of Exercise Programs

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Chronic heart failure (from New York Heart Association (NYHA) functional class II to NYHA III) Left ventricular ejection fraction below or equal to 35% Exclusion Criteria: Uncontrolled arrhythmia Pulmonary oedema or pulmonary congestion in the last 30 days Cognitive, neurological or orthopaedic limitations Respiratory infection during 30 days before the start of the study Pulmonary limitations (e.g COPD)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stamatis Adamopoulos, MD
Organizational Affiliation
Onassis Cardiac Surgery Center
Official's Role
Study Chair
Facility Information:
Facility Name
Onassis Cardiac Surgery Center
City
Athens
State/Province
Attica
ZIP/Postal Code
176 74
Country
Greece
Facility Name
Asklepieion Voulas General Hospital
City
Voula
State/Province
Attica
ZIP/Postal Code
16673
Country
Greece
Facility Name
Telecardiology Center, Institute of Cardiology
City
Warsaw
ZIP/Postal Code
04-828
Country
Poland

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
22658571
Citation
Laoutaris ID, Adamopoulos S, Manginas A, Panagiotakos DB, Kallistratos MS, Doulaptsis C, Kouloubinis A, Voudris V, Pavlides G, Cokkinos DV, Dritsas A. Benefits of combined aerobic/resistance/inspiratory training in patients with chronic heart failure. A complete exercise model? A prospective randomised study. Int J Cardiol. 2013 Sep 1;167(5):1967-72. doi: 10.1016/j.ijcard.2012.05.019. Epub 2012 May 31.
Results Reference
background
PubMed Identifier
24634346
Citation
Adamopoulos S, Schmid JP, Dendale P, Poerschke D, Hansen D, Dritsas A, Kouloubinis A, Alders T, Gkouziouta A, Reyckers I, Vartela V, Plessas N, Doulaptsis C, Saner H, Laoutaris ID. Combined aerobic/inspiratory muscle training vs. aerobic training in patients with chronic heart failure: The Vent-HeFT trial: a European prospective multicentre randomized trial. Eur J Heart Fail. 2014 May;16(5):574-82. doi: 10.1002/ejhf.70. Epub 2014 Mar 14.
Results Reference
background
PubMed Identifier
18515805
Citation
Beckers PJ, Denollet J, Possemiers NM, Wuyts FL, Vrints CJ, Conraads VM. Combined endurance-resistance training vs. endurance training in patients with chronic heart failure: a prospective randomized study. Eur Heart J. 2008 Aug;29(15):1858-66. doi: 10.1093/eurheartj/ehn222. Epub 2008 May 30.
Results Reference
background
PubMed Identifier
24294043
Citation
Smart NA. How do cardiorespiratory fitness improvements vary with physical training modality in heart failure patients? A quantitative guide. Exp Clin Cardiol. 2013 Winter;18(1):e21-5.
Results Reference
background
PubMed Identifier
33624071
Citation
Laoutaris ID, Piotrowicz E, Kallistratos MS, Dritsas A, Dimaki N, Miliopoulos D, Andriopoulou M, Manolis AJ, Volterrani M, Piepoli MF, Coats AJS, Adamopoulos S; ARISTOS-HF trial (Aerobic, Resistance, InSpiratory Training OutcomeS in Heart Failure) Investigators. Combined aerobic/resistance/inspiratory muscle training as the 'optimum' exercise programme for patients with chronic heart failure: ARISTOS-HF randomized clinical trial. Eur J Prev Cardiol. 2021 Dec 29;28(15):1626-1635. doi: 10.1093/eurjpc/zwaa091.
Results Reference
derived

Learn more about this trial

Aerobic, Resistance, Inspiratory Training Outcomes in Heart Failure

We'll reach out to this number within 24 hrs